Volume 10 (2026)
Cover: Public domain image of an artist's impression of a neuron network. Image by Jean Beaufort (Link). Image modified by Cell Stress. The cover is published under the CC BY 4.0 license
MicroRNA as key players in skin regeneration and anti-aging pathways
Hanieh Azizi1, Reza Moghadasali2, Amir Mohammad Amirkhani3, Ehsan Taghiabadi3 and Mohammad Ali Nilforoushzadeh3,4
This review highlights current knowledge of miRNA-mediated regulation in skin regeneration and aging and synthesizes recent findings on their individual functions in these biological processes.
Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
Flavia Lambertucci1, David Skurnik2,3, Damien Roux4,5, Laurence Arbibe6, Lucillia Bezu1,7,8, Isabelle Martins1 and Guido Kroemer1,7,9
This review advances the hypothesis that benzodiazepines should be preferentially substituted by alternative sedative strategies in septic shock and critical illness, and that ACBP/DBI is a mechanistically grounded biomarker and therapeutic target linking sedation biology, immune dysfunction and accelerated aging.
Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages
Ziqi Chen1,2,a, Jie Zhang3,a, Jianting Lao4, Chaoqin Yu5 and Hong Yang1,4
Our findings indicate that the suppression of ovarian cancer by Triptolide is mediated in part through its capacity to reprogram TAMs via the Nrf2 pathway.
The IRE1α-XBP1s-NFκB axis controls cell survival and epithelial differentiation under osmotic stress through arachidonic acid metabolism activation
Leandro Gastón Parra1,5, Cecilia Irene Casali1,5, Dylan Ezequiel Sendyk1,5, Ailén Florencia Salafia1, Sabrina Andrea Flor3,4,6, Silvia Edith Lucangioli2,4,6 and María del Carmen Fernández Tome1,5,*
Our findings highlight a central role for the IRE-XBP1s-NFB signaling axis in coordinating cell stress responses and epithelial differentiation through AA metabolism activation.
Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential
Shima Ebadollahibaruq1,2, Lingbin Meng2 and Feng Hong1,2,*
This review meticulously dissects CNPY2’s structural characteristics, expression patterns, and biological functions across various disorders, emphasizing its role on tumor initiation, microenvironmental stress, and chemoresistance, and evaluating its potential as a therapeutic target.
Antifungal peptides: from modes of action to synergistic and immunologic potential
Didac Carmona-Gutierrez1,2,#,*, Maria A. Bauer1,#, Katharina Kainz1¸ Martin N. Odabas1 and Frank Madeo1-3,*
This review underscores the potential of AFPs as viable candidates for the development of next-generation antifungal therapies, advocating their multimodal advantage that spans beyond standalone activity, including their synergistic and immune-regulatory potential.
Reversal of Cushing syndrome by antibody-mediated neutralization of ACBP/DBI
Zhe Shen1,2,3,a, Hui Pan1,2,4,a, Xiaolian Deng1,2,3, Oliver Kepp1,2, Isabelle Martins1,*, and Guido Kroemer1,2,5,*
This study investigates the therapeutic potential of ACBP/DBI neutralization in a well-established murine model of CS, positioning ACBP/DBI neutralization as a viable therapeutic strategy for established CS.
MicroRNA as key players in skin regeneration and anti-aging pathways
Hanieh Azizi1, Reza Moghadasali2, Amir Mohammad Amirkhani3, Ehsan Taghiabadi3 and Mohammad Ali Nilforoushzadeh3,4
This review highlights current knowledge of miRNA-mediated regulation in skin regeneration and aging and synthesizes recent findings on their individual functions in these biological processes.
Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
Flavia Lambertucci1, David Skurnik2,3, Damien Roux4,5, Laurence Arbibe6, Lucillia Bezu1,7,8, Isabelle Martins1 and Guido Kroemer1,7,9
This review advances the hypothesis that benzodiazepines should be preferentially substituted by alternative sedative strategies in septic shock and critical illness, and that ACBP/DBI is a mechanistically grounded biomarker and therapeutic target linking sedation biology, immune dysfunction and accelerated aging.
Triptolide inhibits ovarian cancer growth and metastasis via reprogramming of tumor-associated macrophages
Ziqi Chen1,2,a, Jie Zhang3,a, Jianting Lao4, Chaoqin Yu5 and Hong Yang1,4
Our findings indicate that the suppression of ovarian cancer by Triptolide is mediated in part through its capacity to reprogram TAMs via the Nrf2 pathway.
The IRE1α-XBP1s-NFκB axis controls cell survival and epithelial differentiation under osmotic stress through arachidonic acid metabolism activation
Leandro Gastón Parra1,5, Cecilia Irene Casali1,5, Dylan Ezequiel Sendyk1,5, Ailén Florencia Salafia1, Sabrina Andrea Flor3,4,6, Silvia Edith Lucangioli2,4,6 and María del Carmen Fernández Tome1,5,*
Our findings highlight a central role for the IRE-XBP1s-NFB signaling axis in coordinating cell stress responses and epithelial differentiation through AA metabolism activation.
MicroRNA as key players in skin regeneration and anti-aging pathways
Hanieh Azizi1, Reza Moghadasali2, Amir Mohammad Amirkhani3, Ehsan Taghiabadi3 and Mohammad Ali Nilforoushzadeh3,4
This review highlights current knowledge of miRNA-mediated regulation in skin regeneration and aging and synthesizes recent findings on their individual functions in these biological processes.
Multifaceted role of CNPY2 beyond ER stress: Disease implications and therapeutic potential
Shima Ebadollahibaruq1,2, Lingbin Meng2 and Feng Hong1,2,*
This review meticulously dissects CNPY2’s structural characteristics, expression patterns, and biological functions across various disorders, emphasizing its role on tumor initiation, microenvironmental stress, and chemoresistance, and evaluating its potential as a therapeutic target.
Antifungal peptides: from modes of action to synergistic and immunologic potential
Didac Carmona-Gutierrez1,2,#,*, Maria A. Bauer1,#, Katharina Kainz1¸ Martin N. Odabas1 and Frank Madeo1-3,*
This review underscores the potential of AFPs as viable candidates for the development of next-generation antifungal therapies, advocating their multimodal advantage that spans beyond standalone activity, including their synergistic and immune-regulatory potential.
Stress management by benzodiazepines in septic shock and critical illness: mechanistic and clinical evidence supporting alternative sedative strategies
Flavia Lambertucci1, David Skurnik2,3, Damien Roux4,5, Laurence Arbibe6, Lucillia Bezu1,7,8, Isabelle Martins1 and Guido Kroemer1,7,9
This review advances the hypothesis that benzodiazepines should be preferentially substituted by alternative sedative strategies in septic shock and critical illness, and that ACBP/DBI is a mechanistically grounded biomarker and therapeutic target linking sedation biology, immune dysfunction and accelerated aging.